Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

NuVasive

Biotech & Life Sciences · San Diego, United States · Founded 1997 · IPO 2004 Thoroughbred

Medical device company developing minimally disruptive surgical products and procedurally integrated solutions for the spine

Valuation
$2.91B
Market cap · 2026
Revenue
$1.20B
Latest reported FY
EBITDA
$212M
Latest reported FY

Investors

4 investors on NuVasive's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Kleiner Perkins
Enterprise Partners
Pappas Capital
Series B+ 1 investor entered at this stage
Domain Associates

Global footprint

Where NuVasive has talent and traffic

Workforce by country
26 countries with
team presence
🇺🇸 United States77.2%
🇧🇷 Brazil3.8%
🇩🇪 Germany3.1%
🇦🇺 Australia2.9%
🇳🇱 Netherlands2.6%
Top 5 of 26 shown
Web traffic by country
130K monthly visits
across markets
🇺🇸 United States98.5%
🇮🇳 India1%
🇬🇧 United Kingdom0.8%
🇮🇹 Italy0.6%
🇯🇵 Japan0.3%
Top 5 markets shown

Capital deployed

NuVasive's 4 investments and acquisitions.

Every disclosed deal where NuVasive appeared as a backer or acquirer, 2016–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across NuVasive's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        NuVasive's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about NuVasive

        An AI-synthesized read of the highest-engagement posts about NuVasive on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See NuVasive on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.